JAK2 Mutation: Clinical Trials

1 trial for JAK2 Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow JAK2 Mutation: new trials by email Literature Review of JAK2 Mutation trials Research Report on JAK2 Mutation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis
Ropeginterferon - JAK2 Mutation
Phase 1RecruitingBrigham and Women's Hospital122026-07-242026-07-28

Narrower conditions

Myeloproliferative Disorders (1)

Broader conditions

Bone Marrow Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)

Sponsors

Brigham and Women's Hospital (1)

Countries

United States (1)

Top investigators

Chi-Joan How (1)